Project Grant R56MH142785
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a Project Grant of $197,640 under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025 through August 31, 2030. This award supports an early-career investigator's research into the functional consequences of schizophrenia-associated genetic variants in GRIA3, a gene encoding the GluA3 subunit of the AMPA receptor...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a Project Grant totaling $608,086 under the Mental Health Research Grants program (CFDA 93.242), effective March 24, 2026 through December 31, 2029. This award funds basic neuroscience research investigating the functional role of the claustrum in cognitive flexibility and adaptive decision-making. The research employs electrophysiological recording and circuit manipulation...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a $427,625 Project Grant (CFDA 93.242 – Mental Health Research Grants) effective May 15, 2026 through April 30, 2028 to develop innovative molecular tools for rapidly inactivating target proteins in live animal brains during memory consolidation. The project, titled "CHEMI-KNOCK: Achieving Rapidly Inducible Loss-of-Function in Live Animal Brains During Memory...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $427,625 Project Grant to the University of Maryland, Baltimore (effective September 11, 2025 through September 10, 2027) under the Mental Health Research Grants program (CFDA 93.242) to fund basic neuroscience research on synaptic transmission mechanisms. The project focuses on identifying and characterizing the molecular organization of docked synaptic vesicles at presynaptic active zones and...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant of $121,933.00 to the University of California, San Diego under the Mental Health Research Grants program (CFDA 93.242) for the period of June 1, 2025 through May 31, 2027. This research project will deliver scientific investigation into compartment-specific synaptic organization and plasticity in layer 2/3 pyramidal neurons during learning in behaving animals. The research employs cutting-edge...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a Project Grant totaling $104,349 under the Mental Health Research Grants program (CFDA 93.242) for research on "Attentional Modulation of Neural Activity in Multi-Attribute Decision Making." The award, effective April 1, 2026 through March 31, 2028, supports basic neuroscience research investigating how attention influences neural decision-making processes across human and...
- Federal Grant Award Summary Award Details: The National Institute of Mental Health (NIMH) awarded Tufts University School of Medicine a Project Grant totaling $182,916 under the Mental Health Research Grants program (CFDA 93.242) on October 17, 2025, with an ultimate completion date of October 23, 2027. Research Scope and Deliverables: This project investigates cell type-specific mechanisms of glutamatergic synapse function and organization, with a focus on how the protein BTBD11 regulates...
- Federal Grant Award Summary Cold Spring Harbor Laboratory received a $528,000 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective June 19, 2026 through June 18, 2028. The award funds research investigating the developmental characterization of synapses between neurons and oligodendrocyte precursor cells (OPCs). This research addresses a significant gap in neuroscience understanding by examining a...
- Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a $538,657 Project Grant on July 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and validate the Neural Navigator platform—a standardized computational tool for identifying circuit-level dysfunction signatures in patient-derived cerebral organoids. The project addresses a critical translational gap in understanding schizophrenia and bipolar disorder by...
- Federal Project Grant Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University a $388,646 Project Grant effective June 16, 2026, through May 31, 2031, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research will investigate the molecular mechanisms of Delta-2 receptor (GluD2) dysfunction in neurological diseases, with particular focus on cerebellar ataxia, autism spectrum...
The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a Project Grant of $776,233 under the Mental Health Research Grants program (CFDA 93.242) to conduct basic research investigating novel molecular mechanisms underlying synaptic plasticity and cognition. The award, effective July 2, 2026 through June 30, 2028, supports comprehensive research examining the structure and function of SYNGAP1, a protein critical to glutamatergic synapse regulation. The research team will employ molecular biological, biochemical, cell biological, and in vivo studies to characterize how SYNGAP1 regulates synapse complex formation and to elucidate the noncanonical RNA splicing mechanisms of the SYNGAP1 A1 splice variant, which represents the most significant isoform for synaptic plasticity and cognitive function. This research directly addresses the molecular basis of neurodevelopmental disorders associated with SYNGAP1 mutations, including intellectual disability, autism spectrum disorder, and epilepsy. The findings are expected to advance fundamental understanding of synaptic mechanisms underlying learning, memory, and cognitive processes, with potential implications for therapeutic interventions targeting these debilitating conditions. The project builds upon preliminary discoveries indicating that SYNGAP1's structural role at the synapse, rather than its catalytic activity, is essential for normal synaptic function and behavior.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $776.2k | 7/7/26 |